Possible to make new Covid strain vax in 100 days: Gennova BioPharma

Co gets nod for Omicron booster of its mRNA vaccine

Pune-based Gennova BioPharmaceuticals, which developed the country’s first mRNA vaccine and has now obtained approval for a mix-and-match booster dose based on the Omicron strain of the Sars-CoV-2 virus, says it can make a new vaccine based on an emerging strain within 100-days, if need be.

Speaking to the media, Sanjay Singh, CEO, Gennova said the firm was in discussions with the Coalition for Epidemic Preparedness Innovations (CEPI) on the matter. “Developing a vaccine on any new strain within 100 days is feasible, and globally such discussions are on. We are also in discussions with CEPI on this matter. Whether